Rotate to portrait

Vizual Stocks works best vertically on mobile.

VizualStocks API
PUBLIC DATA DEFINITIONS

Recursion Pharmaceuticals KPI & segment coverage

Operating KPI and segment definitions available for Recursion Pharmaceuticals (RXRX) through the VizualStocks API.

RXRX4 metric seriesCatalog checked 2026-10-28

Active metrics 4

SEGMENT

Grant Revenue

Revenue recognized from grants supporting Recursion's research activities, separate from operating revenue from commercial collaborations. Negative reported amounts represent grant-revenue adjustments rather than missing values.

grantRevenue
Frequency
quarterly / annual
Reported history
Q4'24 — Q2'26
History endpoint
SEGMENT

Operating Revenue

Revenue from Recursion's research and development collaborations and other operating activities, recognized as contractual services are performed. Excludes separately reported grant revenue and is distinct from collaboration cash receipts or potential milestone payments.

operatingRevenue
Frequency
quarterly / annual
Reported history
Q4'24 — Q2'26
History endpoint
SEGMENT

United Kingdom Revenue

Recursion revenue attributed to the United Kingdom based on where research services are performed, rather than the customer's headquarters. Reported annually; the November 2024 Exscientia acquisition changes the operating perimeter.

unitedKingdomRevenue
Frequency
annual
Reported history
2024 — 2025
History endpoint
SEGMENT

United States Revenue

Recursion revenue attributed to the United States based on where research services are performed, rather than the customer's headquarters. Reported annually; the November 2024 Exscientia acquisition changes the operating perimeter.

unitedStatesRevenue
Frequency
annual
Reported history
2023 — 2025
History endpoint